Dear Spinal Muscular Atrophy Community Members, We would like to update you on the clinical development of RG7800, an investigational SMN2 splicing modifier that is being studied as a potential treatment for spinal muscu - Spinal muscular atrophy - Document - PDFSEARCH.IO

First Page	Meta Content
	Dear Spinal Muscular Atrophy Community Members, We would like to update you on the clinical development of RG7800, an investigational SMN2 splicing modifier that is being studied as a potential treatment for spinal muscu Add to Reading List Document Date: 2015-05-07 03:16:04 Open Document File Size: 52,48 KB Share Result on Facebook Company Rare Diseases F. Hoffmann-La Roche Ltd / / IndustryTerm study protocol / / MedicalCondition spinal muscular atrophy / / Organization SMA Foundation / / Person Luca Santarelli / Stuart Peltz / / Position CEO PTC Therapeutics Loren Eng President / VP / Head / / Technology Neuroscience / study protocol / pharmacokinetics / / SocialTag Motor neurone disease Spinal muscular atrophy

Dear Spinal Muscular Atrophy Community Members, We would like to update you on the clinical development of RG7800, an investigational SMN2 splicing modifier that is being studied as a potential treatment for spinal muscuAdd to Reading List